Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Cell Programming Company Raises $49.5M in Early Funds

A start-up enterprise creating add-on treatments that program the effects of cell and gene therapies is raising $49.5 million in its first venture funding round. . . . → Read More: Cell Programming Company Raises $49.5M in Early Funds

Drug Price Report Calls for Govt Negotiation, More Generics

A panel convened by the National Academies calls for the federal government to use its buying power to negotiate better drug prices for consumers. . . . → Read More: Drug Price Report Calls for Govt Negotiation, More Generics

New Finance, Development Model for Pancreatic Disease

An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis. . . . → Read More: New Finance, Development Model for Pancreatic Disease

Ways to Invest Without Playing the Stock Market

Taking your chances on the stock market right now is not only a scary prospect but may not be the best idea right now. . . . → Read More: Ways to Invest Without Playing the Stock Market

Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Drug maker Novartis is purchasing a company that develops therapies and diagnostics using radio isotopes for neuroendocrine and other cancers. . . . → Read More: Novartis Acquires Nuclear Meds Developer in $3.9B Deal

Multi-Drug Resistance Antibiotic Developer to Issue IPO

A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering. . . . → Read More: Multi-Drug Resistance Antibiotic Developer to Issue IPO

Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology. . . . → Read More: Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal

Infographic – Europe’s High Value Tech Companies

Our friends at Statista this week collected the top European technology companies in market value, displayed in this chart. . . . → Read More: Infographic – Europe’s High Value Tech Companies

Infographic – Google’s Largest Acquisitions

Our friends at Statista yesterday published this chart showing Google/Alphabet’s largest acquisitions over the years. . . . → Read More: Infographic – Google’s Largest Acquisitions

Neuro Disease Start-Up Gains $30M in Early Funds

A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round. . . . → Read More: Neuro Disease Start-Up Gains $30M in Early Funds